Jun 7, 2017
What could possibly go wrong?
Bioquark is about to begin a trial that will attempt to bring brain-dead patients back to life using stem cells. However, the trial is raising numerous scientific and ethical questions for other experts in the field.
Researchers seem to be setting their sights on increasingly lofty goals when it comes to the human body – from the world's first human head transplant, to fighting ageing, and now reversing death altogether.
Yes, you read that right. A company called Bioquark hopes to bring people who have been declared clinically brain-dead back to life. The Philadelphia-based biotech company is expected to start on the project later this year.
Continue Reading.
